Product NDC: | 55111-681 |
Proprietary Name: | Fondaparinux Sodium |
Non Proprietary Name: | Fondaparinux Sodium |
Active Ingredient(s): | 10 mg/.8mL & nbsp; Fondaparinux Sodium |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-681 |
Labeler Name: | Dr. Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091316 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110714 |
Package NDC: | 55111-681-02 |
Package Description: | 2 SYRINGE in 1 CARTON (55111-681-02) > .8 mL in 1 SYRINGE (55111-681-11) |
NDC Code | 55111-681-02 |
Proprietary Name | Fondaparinux Sodium |
Package Description | 2 SYRINGE in 1 CARTON (55111-681-02) > .8 mL in 1 SYRINGE (55111-681-11) |
Product NDC | 55111-681 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fondaparinux Sodium |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20110714 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Limited |
Substance Name | FONDAPARINUX SODIUM |
Strength Number | 10 |
Strength Unit | mg/.8mL |
Pharmaceutical Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |